Compositions and methods for treating pulmonary disease with matrix metalloproteinase inhibitors
AssigneeDarsha LLC
InventorJeanine D'Armiento
Life of this patent
Estimating the term…
Abstract
Disclosed in certain embodiments is a method of treating a pulmonary disease comprising administering a therapeutically effective amount of a Matrix Metalloproteinase (MMP) Inhibitor to a patient in need thereof wherein the pulmonary disease is selected from the group consisting of Acute Respiratory Distress Syndrome, Acute Lung Injury and Acute Inflammatory Injury, and compositions thereof.
Claims23
A method of treating a pulmonary disease comprising administering via pulmonary delivery a therapeutically effective amount of a Matrix Metalloproteinase (MMP) Inhibitor to a patient in need thereof wherein the pulmonary disease is selected from the group consisting of Acute Respiratory Distress Syndrome, Acute Lung Injury and Acute Inflammatory Injury.
A pharmaceutical composition comprising an effective amount of a Matrix Metalloproteinase (MMP) Inhibitor to for treating Acute Respiratory Distress Syndrome and a pharmaceutically acceptable excipient suitable for pulmonary administration.
-22. (canceled)
(canceled)
-37. (canceled)
Dependencies are inferred from the claim text.